[go: up one dir, main page]

DE3878812D1 - Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen. - Google Patents

Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.

Info

Publication number
DE3878812D1
DE3878812D1 DE8888902675T DE3878812T DE3878812D1 DE 3878812 D1 DE3878812 D1 DE 3878812D1 DE 8888902675 T DE8888902675 T DE 8888902675T DE 3878812 T DE3878812 T DE 3878812T DE 3878812 D1 DE3878812 D1 DE 3878812D1
Authority
DE
Germany
Prior art keywords
omega
fatty acids
those suffering
traumatic injury
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888902675T
Other languages
English (en)
Other versions
DE3878812T2 (de
Inventor
Wesley Alexander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHRINERS HOSPITALS FOR CRIPPLE
Original Assignee
SHRINERS HOSPITALS FOR CRIPPLE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHRINERS HOSPITALS FOR CRIPPLE filed Critical SHRINERS HOSPITALS FOR CRIPPLE
Publication of DE3878812D1 publication Critical patent/DE3878812D1/de
Application granted granted Critical
Publication of DE3878812T2 publication Critical patent/DE3878812T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
DE8888902675T 1987-02-20 1988-02-19 Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen. Expired - Lifetime DE3878812T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1732687A 1987-02-20 1987-02-20
PCT/US1988/000504 WO1988006035A1 (en) 1987-02-20 1988-02-19 Omega-3 fatty acids in traumatic injury treatment

Publications (2)

Publication Number Publication Date
DE3878812D1 true DE3878812D1 (de) 1993-04-08
DE3878812T2 DE3878812T2 (de) 1993-07-22

Family

ID=21781968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888902675T Expired - Lifetime DE3878812T2 (de) 1987-02-20 1988-02-19 Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.

Country Status (5)

Country Link
EP (1) EP0310639B1 (de)
AT (1) ATE86108T1 (de)
AU (1) AU1489688A (de)
DE (1) DE3878812T2 (de)
WO (1) WO1988006035A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
EP0665721A1 (de) * 1992-10-30 1995-08-09 Cancer Research Fund Of Contra Costa Antidiarrhöeprodukt und verfahren zur behandlung einer rotavirusinfektion
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
DE4341000A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
FR2723315B1 (fr) * 1994-08-02 1996-10-25 Cird Galderma Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes
DE4432633C2 (de) * 1994-09-14 1997-07-31 Singer Peter Dr Med Priv Doz Pharmazeutisches Präparat zur lokalen Behandlung von Schuppenflechte, Neurodermitis und Ekzem
GB9419345D0 (en) * 1994-09-26 1994-11-09 Sandoz Nutrition Ltd Organic compounds
CA2516142A1 (en) * 2003-03-18 2004-09-30 Novartis Ag Compositions comprising fatty acids and amino acids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2124087A3 (en) * 1971-02-04 1972-09-22 Kouroutzeff Kir Mothers' milk substitute - contg easily digestible degraded proteins,lipids and glucides
JPS57110176A (en) * 1980-12-27 1982-07-08 Snow Brand Milk Prod Co Ltd Nutrious food composition for tube feeding
EP0087863B1 (de) * 1982-03-01 1986-05-21 Efamol Limited Pharmazeutische und diätetische Zusammensetzung
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters

Also Published As

Publication number Publication date
EP0310639A1 (de) 1989-04-12
EP0310639B1 (de) 1993-03-03
WO1988006035A1 (en) 1988-08-25
AU1489688A (en) 1988-09-14
ATE86108T1 (de) 1993-03-15
EP0310639A4 (de) 1989-11-30
DE3878812T2 (de) 1993-07-22

Similar Documents

Publication Publication Date Title
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
ES2185744T3 (es) Composicion nutritiva.
SE8405308L (sv) Farmaceutisk komposition och forfarande for framstellning av densamma
DE3881815D1 (de) Isotone omega-3-fettsaeurenhaltige fettemulsion und ihre verwendung.
IT1235879B (it) Composizione di acidi grassi comprendente almeno 80% in peso di acidi grassi poliinsaturi omega-3
ATE88631T1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DK0539448T3 (da) Levnedsmiddelsammensætninger og farmaceutiske sammensætninger indeholdende kortkædede, monoumættede fedtsyrer og fremgangsmåde til anvendelse
IL137848A (en) Indole-3-propionic acids and salts and esters thereof for use as medicaments
DE69816568D1 (de) Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost
DE3878812D1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE69312579D1 (de) Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit
ATE143261T1 (de) Zusammensetzung zur behandlung entzündlicher darmerkrankungen
ATE11014T1 (de) Pharmazeutische und diaetetische zusammensetzung zur erhoehung der serie-l-pg-produktion.
ATE167983T1 (de) Phospholipidhaltige fettmischung mit lcp- fettsäuren
Campbell Clinical use of fatty acid supplements in dogs
ATE209487T1 (de) Verfahren zur behandlung von krebs mittels strukturierten lipiden
ES2037265T3 (es) Nuevo aceite dietetico.
ATE74762T1 (de) Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien).
DE3750426D1 (de) Mittel zur Verbesserung spezifischer Eigenschaften des Blutes.
SE8800989D0 (sv) Dietary composition and process for preparing same
SE8800990L (sv) Hudregenererande kosmetisk komposition samt foerfarande foer framstaellning av densamma
SE8800101D0 (sv) Anvendning av essentiella fettsyror for framstellning av ett preparat for behandling av eksem
RU2118896C1 (ru) Противоожоговое и ранозаживляющее средство
ATE326973T1 (de) Neue verwendung von phospholiden pflanzlichen und tierischen ursprungs in nahrungstherapie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition